文献速递区域麻醉与超声疼痛医学

鞘内二乙酰吗啡的有效性与安全性:系统评价、Meta分析与试验序贯分析

Efficacy and safety of intrathecal diamorphine: a systematic review and meta-analysis with meta-regression and trial sequential analysis.
PubMed 文献 · Anaesthesia · 2024-06-23

该系统评价纳入12项试验共712例患者,比较鞘内二乙酰吗啡与对照组。结果显示鞘内二乙酰吗啡显著减少术后24小时静脉吗啡消耗量,但增加术后恶心呕吐发生率,证据质量极低。

要点

  • 鞘内二乙酰吗啡减少术后24小时静脉吗啡消耗,平均差-8 mg(95%CI -11至-6)。
  • 鞘内二乙酰吗啡增加术后恶心呕吐风险,风险比1.37(95%CI 1.19-1.58)。
  • 剂量>200 μg时恶心呕吐增加,但各剂量亚组间无差异。

核心结论

  • 极低质量证据表明鞘内二乙酰吗啡可提供有效术后镇痛,但剂量>200 μg时增加术后恶心呕吐。

研究设计与样本

  • 系统评价与Meta分析,纳入12项比较鞘内二乙酰吗啡与对照组的试验,共712例患者。

主要发现

  • 术后24小时静脉吗啡消耗量显著减少,平均差-8 mg(95%CI -11至-6),I2=93%,p<0.001。
  • 三个剂量亚组(0-200 μg、201-400 μg、>400 μg)间有显著差异但无相关性,平均差分别为-1 mg(-3至0)、-26 mg(-40至-11)、-6 mg(-15至4),p=0.003。
  • 术后恶心呕吐风险增加,风险比1.37(95%CI 1.19-1.58),I2=7%,p<0.001。
  • 三个剂量亚组间术后恶心呕吐无差异。
  • 所有结局证据质量极低。

关键数值与推荐

  • 鞘内二乙酰吗啡剂量范围为100 μg至2500 μg。
  • 主要疗效结局为术后24小时静脉吗啡消耗量,主要安全结局为术后24小时恶心呕吐发生率。

临床怎么用

  • 鞘内二乙酰吗啡可用于术后镇痛,但需注意剂量>200 μg时恶心呕吐风险增加。
  • 临床决策应结合极低证据质量谨慎权衡获益与风险。

局限性

  • 所有结局证据质量极低。
  • 异质性高(I2=93%)。
  • Meta回归未观察到主要疗效和 safety 结局的相关性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Intrathecal diamorphine is believed to provide postoperative analgesia but is associated with adverse effects such as nausea and vomiting. There is little evidence of synthesis regarding intrathecal diamorphine in the contemporary literature. We performed a systematic review, meta-analysis with meta-regression and trial sequential analysis to determine the magnitude of intrathecal diamorphine efficacy and safety. METHODS: We systematically searched the literature for trials comparing intrathecal diamorphine with a control group in patients undergoing all types of surgery. The primary efficacy and safety outcomes were intravenous morphine consumption and incidence of postoperative nausea and vomiting at 24 h following surgery, respectively. RESULTS: Twelve trials were identified, which included data for 712 patients. Intrathecal doses of diamorphine ranged from 100 μg to 2500 μg. Intravenous morphine consumption at 24 h postoperatively was significantly reduced in the intrathecal diamorphine group, with a mean difference (95%CI) of -8 mg (-11 to -6), I2 = 93%, p < 0.001. There was a significant difference between three intrathecal diamorphine dosing subgroups but without correlation: mean differences (95%CI) -1 mg (-3-0), -26 mg (-40 to -11) and -6 mg (-15-4) in patients receiving doses of 0-200 μg, 201-400 μg and > 400 μg, respectively (p = 0.003). Intrathecal diamorphine increased postoperative nausea and vomiting with a risk ratio (95%CI) of 1.37 (1.19-1.58), I2 = 7%, p < 0.001. There were no differences in postoperative nausea and vomiting between the three intrathecal diamorphine dosing subgroups. There was no correlation observed with meta-regression of the primary efficacy and safety outcomes. The quality of evidence for all outcomes was very low. CONCLUSION: There is very low level of evidence that intrathecal diamorphine provides effective analgesia after surgery, while increasing postoperative nausea and vomiting with doses > 200 μg.

来源:Anaesthesia,查看原文。版权归原作者所有。

引用

  1. Grape S, El-Boghdadly K, Jaques C, et al. Efficacy and safety of intrathecal diamorphine: a systematic review and meta-analysis with meta-regression and trial sequential analysis. Anaesthesia. 2024. PMID: 38922818. doi:10.1111/anae.16359

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。